AI-Generated Summary
Amanta Healthcare's shares made a strong market debut on NSE, listing at ₹135, a 7.14% premium over its IPO price of ₹126. The IPO was highly oversubscribed, with overall demand reaching 82.61 times. Proceeds from the ₹126 crore fresh issue will primarily fund new manufacturing lines for sterile liquid products in Hariyala, Kheda, Gujarat.
In a nutshell
This successful IPO and the planned investment in new manufacturing facilities in Kheda highlight a significant boost for Gujarat's pharmaceutical sector and local economy, attracting capital and creating potential job opportunities.
Source: Livemint
